Clearing the Clutter

Courtesy of ESAWhen it comes to metabolomics, there can be such a thing as too much information. The blossoming science typically uses mass spectrometry and nuclear magnetic resonance (NMR) to hunt for specific metabolites as markers of abnormal biological processes. "But those devices aren't geared to analyze samples like serum or urine that may have thousands of individual components," says Paul Gamache, director of applications development for ESA http://www.esainc.com in Chelmsford, Mass. "T

Written byBennett Daviss
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Courtesy of ESA

When it comes to metabolomics, there can be such a thing as too much information. The blossoming science typically uses mass spectrometry and nuclear magnetic resonance (NMR) to hunt for specific metabolites as markers of abnormal biological processes. "But those devices aren't geared to analyze samples like serum or urine that may have thousands of individual components," says Paul Gamache, director of applications development for ESA http://www.esainc.com in Chelmsford, Mass. "Those tools are very sensitive and were developed for other applications using samples that are more pure," he adds.

When confronted with a welter of disparate compounds, the instruments can have trouble sorting through them to discern whether a few crucial ones are present, complicating data analysis. Adds Gamache: "People use these instruments for metabolomic research just because they already have them."

Now there is a complementary option. ESA's Metabolomics System uses high-performance liquid chromatography and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies